Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico

Drug and Alcohol Dependence

Volumn 123, Issue 1-3, 2012, Pages 269-272

  Campollo, Octavio ^a   Roman, Sonia ^a   Panduro, Arturo ^a   Hernandez, Gabriel ^a   Diaz Barriga, Lino ^b   Balanzario, Mario C ^b   Cunningham, James K ^c  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b Centros de Integración Juvenil A C   (Mexico)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatitis b virus; Hepatitis c virus; Mexico; Non injection drug use; Prison

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MEXICO; MIXED INFECTION; PRIORITY JOURNAL; VIRUS DETECTION;

ADULT; AGE FACTORS; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MEXICO; PRISONS; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SEX FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TATTOOING; UNSAFE SEX; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84861222719     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.11.009     Document Type: Article

References (34)

1. Alvarado-Esquivel C., Sablon E., Martínez-García S., Estrada-Martínez S. Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Epidemiol. Infect. 2005, 133:679-685.
2. Brown L.D., Cai T.T., DasGupta A. Interval estimation for a binomial proportion. Stat. Sci. 2001, 16:101-133.
3. Bucardo J., Brouwer K.C., Magis-Rodríguez C., Ramos R., Fraga M., Perez S.G., Patterson T.L., Strathdee S.A. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend. 2005, 79:281-293.
4. Caiaffa W.T., Zocratto K.F., Osimani M.L., Martínez P.L., Radulich G., Latorre L., Muzzio E., Segura M., Chiparelli H., Russi J., Rey J., Varquez E., Cuchi P., Sosa-Estani S., Rossi D., Weissenbacher M. Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge?. Addiction 2011, 106:143-151.
5. Camoni L., Regine V., Salfa M.C., Nicoletti G., Canuzzi P., Magliocchetti N., Rezza G., Suligoi B. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study. Scand. J. Infect. Dis. 2009, 41:520-523. The SerT Study Group.
6. Cunningham J.K., Maxwell J.C., Campollo O., Cunningham K.I., Liu L.-M., Lin H.-L. Proximity to the US-Mexico border: a key to explaining geographic variation in US methamphetamine, cocaine and heroin purity. Addiction 2010, 105:1785-1798.
7. Deiss R.G., Lozada R.M., Burgos J.L., Strathdee S.A., Gallardo M., Cuevas J., Garfein R.S. HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico. Global Public Health epub ahead of print 2011, 10.1080/17441692.2010.549141.
8. Ferreira A.D., Caiaffa W.T., Bastos F.I., Mingoti S.A., Projeto AjUDE-Brasil I.I. Injecting drug users who are (un)aware of their HIV serostatus: findings from the multi-center study AjUDE-Brasil II. Cad. Saúde Pública 2006, 22:815-826.
9. Fox R.K., Currie S.L., Evans J., Wright T.L., Tobler L., Phelps B., Busch M.P., Page-Shafer K.A. Hepatitis C virus infection among prisoners in the California state correctional system. Clin. Infect. Dis. 2005, 41:177-186.
10. Haley R., Fischer R.P. Commercial tattooing as a potentially important source of hepatitis C infection: clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001, 80:134-151.
11. International Monetary Fund, 2011. World Economic Outlook Database. April 2011. (accessed 30.06.11). http://www.imf.org/external/pubs/ft/weo/2011/01/weodata/index.aspx.
12. Loebstein R., Mahagna R., Maor Y., Kurnik D., Elbaz E., Halkin H., Olchovsky D., Ezra D., Almog S. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Isr. Med. Assoc. J. 2008, 10:775-778.
13. Macalino G.E., Vlahov D., Sanford-Colby S., Patel S., Sabin K., Salas C., Rich J.D. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am. J. Public Health 2004, 94:1218-1223.
14. Macías J., Palacios R.B., Claro E., Vargas J., Vergara S., Mira J.A., Merchante N., Corzo J.E., Pineda J.A. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Int. 2008, 28:781-786.
15. Magis-Rodríguez C.M., Marques L.F., Touzé G. HIV and injection drug use in Latin America. AIDS 2002, 16:S34-S41.
16. Marín López E.R. Primer consenso nacional de hepatitis B crónica. Rev. Gastroenterol. Mex. 2005, 70:490-503. Grupo del Consenso de Hepatitis.
17. Martinez A., Talal A.H. Noninjection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int. 2008, 28:757-760.
18. Maxwell J.C., Cravioto P., Galván F., Ramírez M.C., Wallisch L.S., Spense R.T. Drug use and risk of HIV/AIDS on the Mexico-USA border: a comparison of treatment admissions in both countries. Drug Alcohol Depend. 2006, 82:S85-S93.
19. Novais A.C.M., Lopes C.L., Reis N.R., Silva A.M., Martins R.M., Souto F.J. Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabά, Mato Grosso, Brazil. Mem. Inst. Oswaldo Cruz 2009, 104:892-896.
20. Rossi D., Goltzman P., Cymerman P., Touzé G., Weissenbacher M. Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome in injection drug users and their partners and children: lessons learned in Latin America-the Argentinean case. Clin. Infect. Dis. 2003, 37:S362-S365.
21. Santos-López G., Sosa-Jurado F., Vallejo-Ruiz V., Meléndez-Mena D., Reyes-Leyva J. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J. Infect. 2008, 56:281-290.
22. Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Des Jarlais D.C., Flom P.L., Strauss S. Non-injection drug use and hepatitis C virus: a systematic review. Drug Alcohol Depend. 2007, 89:1-12.
23. Shirin T., Ahmed T., Iqbal A., Islam M., Islam M.N. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J. Health Popul. Nutr. 2000, 18:145-150.
24. The World Factbook 2011, 2011. Central Intelligence Agency, Washington, DC. (accessed 30.06.11). https://www.cia.gov/library/publications/the-world-factbook/.
25. UNAIDS, 2010. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Joint United Nations Programme on HIV/AIDS. UNAIDS/10 11E JC 1958E.
26. van den Berg C.H.S.B., van de Laar T.J.W., Kok A., Zuure F.R., Coutinho R.A., Prins M. Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J. Viral Hepat. 2009, 16:568-577.
27. Vivas-Arceo C., Benavides S.A., De Jesús Trujillo J., Pandero A., Rivas-Estilla A.M. Hepatitis C virus: prevalence and routes of infection among blood donors of west Mexico. Hepatol. Res. 2003, 25:115-123.
28. Wada K., Greberman S.B., Konuma K., Hirai S. HIV and HCV infection among drug users in Japan. Addiction 1999, 94:1063-1070.
29. Wagner K.D., Pollini R.A., Patterson T.L., Lozada R., Ojeda V.D., Brouwer K.C., Vera A., Volkmann T.A., Strathdee S.A. Cross-border drug injection relationships among injection drug users in Tijuana, Mexico. Drug Alcohol Depend. 2011, 113:236-241.
30. Wang C.C., Krantz E., Klarquist J., Krows M., McBride L., Scott E.P., Shaw-Stiffel T., Weston S.J., Thiede H., Wald A., Rosen H.R. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J. Infect. Dis. 2007, 196:1474-1482.
31. Weinbaum C.M., Sabin K.M., Santibanez S.S. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005, 19:S41-S46.
32. White E.F., Garfein R.S., Brouwer K.C., Lozada R., Ramos R., Firestone-Cruz M., Pérez S.G., Magis-Rodríguez C., Conde-Glez C.J., Strathdee S.A. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Pública Méx. 2007, 49:165-172.
33. Xia X., Luo J., Bai J., Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 2008, 122:990-1003.
34. Zocratto K.F., Osimani M.L., Peralta L.M., Latorre L., Muzzio E., Segura M. Sexual behaviour and HBV infection among noninjecting cocaine users (NICUs). Subst. Use Misuse 2010, 45:2026-2044.